Fulgent Genetics, Inc. (NASDAQ:FLGT) management will conduct a conference call for 9th November 2020 at 4:30 PM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.fulgentgenetics.com
Earnings Expectation
Fulgent Genetics, Inc. is reporting third quarter earnings results on Monday 9th November 2020, after market close.
The consensus estimates from Thomson Reuters are income of $ 0.55 per share from $ 48.46 million in revenue. For the full year, analysts predict revenues of $ 131.99 million, while looking forward to income of $ 1.26 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 135.00 million ~ $ 135.00 million
Click Here For More Historical Outlooks Of Fulgent Genetics, Inc.
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions.
